Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study-Reference-Cited by-同舟云学术

Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study

Published:2014-08-04 Issue:4 Volume:56 Page:882-886
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Alsobhi Enaam,Abrar Mohammed Burhan,Abdelaal Mohammed,Alsaeed Ahmed,Absi Ahmed,Alzahrani Zayed,El-Hemaidi Ihab,Alshehri Mohammed Ali,Warsi Ashraf,Bayashoot Safaa,Hashem Heba,Merdad Anas,Radi Suhaib,Shiekhi Hanadi,Al-Amri Abdulfattah

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.935365

Reference34 articles.

1. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

2. Survival advantage from imatinib compared with the combination interferon-α plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials

3. Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion;Cancers;2024-05-31

2. The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review;International Journal of Clinical Pharmacy;2023-12-26

3. Comparison of morbidity and results of chronic myeloid leukemia treatment in Novosibirsk and the Novosibirsk region;Russian journal of hematology and transfusiology;2023-05-12

4. Outcome of Chronic Myeloid Leukemia-Chronic Phase Patients Treated With Imatinib: A Local Experience;Clinical Lymphoma Myeloma and Leukemia;2018-03

5. Consistency Test between Scoring Systems for Predicting Outcomes of Chronic Myeloid Leukemia in a Saudi Population Treated with Imatinib;International Scholarly Research Notices;2017-02-13